Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.

作者: Can Huang , Shourong Wu , Wenfang Li , Arin Herkilini , Makoto Miyagishi

DOI: 10.1016/J.EBIOM.2019.08.070

关键词:

摘要: Abstract Background Aberrant expression of p53 and its downstream gene p21 is closely related to alterations in cell cycle proliferation, common among cancer patients. However, the underlying molecular mechanism has not been fully unravelled. ZER6 a zinc-finger protein with two isoforms possessing different amino termini (N-termini) their proteins, p52-ZER6 p71-ZER6. The biological function isoforms, as well potential involvement tumourigenesis regulation remain elusive. Methods effect on was determined using specific knockdown overexpression. tumours analysed clinical specimens, while modulation used explore roles regulating proliferation tumourigenesis. p53/p21 axis studied biology biochemical methods. Findings highly expressed tumour tissues, progression. Mechanistically, bound through truncated KRAB (tKRAB) domain N-terminus enhanced MDM2/p53 complex integrity, leading increased ubiquitination degradation. p52-ZER6-silencing induced G0-G1 phase arrest, subsequently reduced Intriguingly, this p52-ZER6, whereas p71-ZER6 did affect stability, most likely due presence HUB-1 domain. Interpretation We identified novel oncogene that enhances might be target for anti-cancer therapy.

参考文章(54)
Paul Roepman, Andreas Schlicker, Josep Tabernero, Ian Majewski, Sun Tian, Victor Moreno, Mireille H Snel, Christine M Chresta, Robert Rosenberg, Ulrich Nitsche, Teresa Macarulla, Gabriel Capella, Ramon Salazar, George Orphanides, Lodewyk FA Wessels, Rene Bernards, Iris M Simon, None, Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition International Journal of Cancer. ,vol. 134, pp. 552- 562 ,(2014) , 10.1002/IJC.28387
Xiao-Xin Sun, Kishore B Challagundla, Mu-Shui Dai, Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1 The EMBO Journal. ,vol. 31, pp. 576- 592 ,(2012) , 10.1038/EMBOJ.2011.434
Kathryn T. Bieging, Stephano Spano Mello, Laura D. Attardi, Unravelling mechanisms of p53-mediated tumour suppression Nature Reviews Cancer. ,vol. 14, pp. 359- 370 ,(2014) , 10.1038/NRC3711
Paul H. Kussie, Svetlana Gorina, Vincent Marechal, Brian Elenbaas, Jacque Moreau, Arnold J. Levine, Nikola P. Pavletich, Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. ,vol. 274, pp. 948- 953 ,(1996) , 10.1126/SCIENCE.274.5289.948
Mark Wade, Yao-Cheng Li, Geoffrey M Wahl, None, MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nature Reviews Cancer. ,vol. 13, pp. 83- 96 ,(2013) , 10.1038/NRC3430
Makoto Miyagishi, Kazunari Taira, Strategies for generation of an siRNA expression library directed against the human genome. Oligonucleotides. ,vol. 13, pp. 325- 333 ,(2003) , 10.1089/154545703322617005
Mirjam T. Epping, Lars A.T. Meijer, Oscar Krijgsman, Johannes L. Bos, Pier Paolo Pandolfi, René Bernards, TSPYL5 suppresses p53 levels and function by physical interaction with USP7 Nature Cell Biology. ,vol. 13, pp. 102- 108 ,(2011) , 10.1038/NCB2142
M. Yamakuchi, C. D. Lotterman, C. Bao, R. H. Hruban, B. Karim, J. T. Mendell, D. Huso, C. J. Lowenstein, P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 6334- 6339 ,(2010) , 10.1073/PNAS.0911082107
Wafik S El-Deiry, Takashi Tokino, Victor E Velculescu, Daniel B Levy, Ramon Parsons, Jeffrey M Trent, David Lin, W Edward Mercer, Kenneth W Kinzler, Bert Vogelstein, WAF1, a potential mediator of p53 tumor suppression Cell. ,vol. 75, pp. 817- 825 ,(1993) , 10.1016/0092-8674(93)90500-P
JT Lee, W Gu, None, The multiple levels of regulation by p53 ubiquitination. Cell Death & Differentiation. ,vol. 17, pp. 86- 92 ,(2010) , 10.1038/CDD.2009.77